Suppr超能文献

肾上腺皮质类固醇与大脑。

Adrenocortical steroids and the brain.

作者信息

Funder J W, Sheppard K

出版信息

Annu Rev Physiol. 1987;49:397-411. doi: 10.1146/annurev.ph.49.030187.002145.

Abstract

In summary, a wide variety of effects of adrenal steroids on the brain have been reported and have been recently and exhaustively reviewed. From the viewpoint of endocrine physiology, however, what is often forgotten is the extraordinary difference in signal level between the two unique products of the adrenal cortex, the mineralocorticoid and glucocorticoid hormones. Levels of cortisol or corticosterone are 2-3 orders of magnitude higher than those of aldosterone, a difference that is tempered by perhaps one order of magnitude by the much higher binding of glucocorticoids to plasma protein. The signal-detecting mechanisms for the lower-intensity signal, i.e. the mineralocorticoid receptor, must therefore have powerful specificity-conferring mechanisms to enable it to recognize, bind, and respond to aldosterone. In vitro studies from a number of laboratories have shown that Type I receptors, in both classic mineralocorticoid target tissues (kidney, parotid, gut) and nontarget tissues (pituitary, hippocampus), cannot distinguish between aldosterone and corticosterone. This finding highlights the problem of aldosterone-selectivity in the kidney (Na+ transport) or the brain (Na+ appetite). In vivo studies, in contrast, show that corticosterone is very poorly taken up and/or retained in kidney, colon, parotid, and pituitary (but not in hippocampus) in mature and 10-day-old (minimal transcortin) rats, whereas aldosterone is well taken up and/or retained by all tissues, evidence for tissue-specific aldosterone selectivity in vivo. Two nonexclusive (i.e. possibly additive) models for such aldosterone selectivity are proposed, one "prebinding" and the other "postbinding". Both models accommodate the experimental findings of the nonselectivity of cytosol preparations in vitro and the stringent specificity seen in in vivo receptor and effector studies. In any real sense, the action of adrenal steroids on the brain is still largely an area of unconnected phenomenology, despite the efforts of a number of talented individuals and groups over the past two decades. Without descriptions of phenomena, even of the most basic ablation and replacement type, we have no chance of making physiological statements. It is equally important, in the attempt to make a coherent physiology, to erect a scaffolding of hypothesis that can be tested against the existing experimental findings and that can serve to suggest further studies in a logical sequence. These hypotheses themselves, and the models used to reify them, may be validated, altered, or rejected by the studies over the next few years.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

总之,肾上腺类固醇对大脑的多种作用已有报道,且最近已进行了详尽的综述。然而,从内分泌生理学的角度来看,人们常常忽略的是肾上腺皮质的两种独特产物,即盐皮质激素和糖皮质激素,在信号水平上存在着巨大差异。皮质醇或皮质酮的水平比醛固酮高2至3个数量级,这种差异因糖皮质激素与血浆蛋白的结合力高得多而有所缓和,可能缩小一个数量级。因此,针对较低强度信号的信号检测机制,即盐皮质激素受体,必须具有强大的赋予特异性的机制,使其能够识别、结合并对醛固酮作出反应。许多实验室的体外研究表明,在经典的盐皮质激素靶组织(肾脏、腮腺、肠道)和非靶组织(垂体、海马体)中的I型受体,无法区分醛固酮和皮质酮。这一发现凸显了在肾脏(钠转运)或大脑(钠食欲)中醛固酮选择性的问题。相比之下,体内研究表明,在成熟和10日龄(最小皮质素)大鼠中,皮质酮在肾脏、结肠、腮腺和垂体(但不在海马体)中的摄取和/或保留非常少,而醛固酮则被所有组织很好地摄取和/或保留,这是体内组织特异性醛固酮选择性的证据。针对这种醛固酮选择性提出了两种并非相互排斥(即可能具有累加性)的模型,一种是“预结合”模型,另一种是“后结合”模型。这两种模型都符合体外细胞溶质制剂非选择性以及体内受体和效应器研究中所见严格特异性的实验结果。实际上,尽管在过去二十年中有许多有才华的个人和团队付出了努力,但肾上腺类固醇对大脑的作用在很大程度上仍然是一个缺乏关联的现象学领域。如果没有对现象的描述,即使是最基本的切除和替代类型的描述,我们也无法做出生理学陈述。在试图构建连贯的生理学体系时,同样重要的是建立一个假设框架,该框架可以根据现有的实验结果进行检验,并能够按逻辑顺序为进一步的研究提供建议。这些假设本身以及用于使其具体化的模型,可能会在未来几年的研究中得到验证、修改或否定。(摘要截取自400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验